title: Is the pharmacological use of intravenous magnesium before preterm cerebroprotective or deleterious for premature infants? Possible importance of the use of magnesium sulphate.
authors.affiliation: SDRM, Hôpital Saint-Vincent-de-Paul, Paris, France.
authors.forename: J
authors.initials: J
authors.lastname: Durlach
authors.forename: P
authors.initials: P
authors.lastname: Bac
authors.forename: M
authors.initials: M
authors.lastname: Bara
authors.forename: A
authors.initials: A
authors.lastname: Guiet-Bara
mesh_terms: D000818:Animals; D002547:Cerebral Palsy / Q000517:prevention & control; D002986:Clinical Trials as Topic; D005260:Female; D005333:Fetus / Q000187:drug effects*; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007275:Injections, Intravenous; D008274:Magnesium / Q000009:adverse effects* / Q000633:toxicity; D017616:Magnesium Compounds / Q000008:administration & dosage / Q000633:toxicity; D008278:Magnesium Sulfate / Q000008:administration & dosage*; D011247:Pregnancy; D015149:Tocolytic Agents / Q000009:adverse effects*
chemical_list: D017616:Magnesium Compounds; D015149:Tocolytic Agents; D008278:Magnesium Sulfate; D008274:Magnesium